Received Aug 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | K25M5 | IM / RL |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 3 | Y015929 | IM |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 3Z34X | PO / MO |
This patient is 6 months old and mom was taking and is currently taking Stelara which is an immunosuppressant. Due to the potential immunosuppression from Stelara crossing the placenta and the possible amount of the immunosuppressive medication crossing into breastmilk, he was not started on the rotavirus vaccination series. He was given the first dose in the series today when he was 6 months of age. Additionally, he received a 3rd Hib vaccine which was not required for his series. Approximately 7-8 hours after administration of the rotavirus vaccine, he developed vomiting and fussiness. He has not developed a fever.
None
Mom was on Stelara while pregnant which can lead to immunosuppression in this child.
None
None
none